Physician profile
David J Carty
NPI 1205802568
$4,919.52
in general payments reported to CMS, 2019-2025
34 companies · $700 in 2025
The $700 reported for 2025 was more than what 79% of Internal Medicine providers received nationally (typical 2025 total: $156).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $916 · 2020: $215 · 2021: $56.46 · 2022: $2,209 · 2023: $384 · 2024: $439 · 2025: $700.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,524.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,523.60 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Biohaven Pharmaceutical Holding Company LTD. | $1,925.28 | 2022 | |
| Glaxosmithkline, LLC. | $491.55 | 2019-2025 | Shingrix, Arexvy, Trelegy Ellipta |
| Lilly USA, LLC | $296.40 | 2019-2025 | Mounjaro, Jardiance, Kisunla |
| Astrazeneca Pharmaceuticals LP | $290.71 | 2019-2025 | Airsupra, Farxiga |
| Novo Nordisk INC | $247.54 | 2019-2025 | Ozempic, Rybelsus, Wegovy |
| Amgen INC. | $244.36 | 2019-2025 | Repatha, Otezla, Evenity |
| Pfizer INC. | $143.57 | 2019-2025 | |
| Exact Sciences Corporation | $118.63 | 2023-2025 | Cologuard Collection Kit |
| Allergan, INC. | $113.90 | 2019 | |
| Astellas Pharma US INC | $98.85 | 2019-2024 | Veozah |
| Otsuka America Pharmaceutical, INC. | $95.09 | 2019-2025 | Jynarque |
| Boehringer Ingelheim Pharmaceuticals, INC. | $88.44 | 2023-2025 | Jardiance, Tradjenta |
| Merck Sharp & Dohme LLC | $87.98 | 2019-2025 | Gardasil 9, Capvaxive, Gardasil |
| Hologic Sales and Service, LLC | $69.26 | 2019-2025 | Aptima |
| Biotronik INC. | $65.16 | 2020 |
Show all 34 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $56.99 | 2023 | Vraylar |
| Amarin Pharma, INC. | $52.69 | 2019-2020 | |
| Takeda Pharmaceuticals U.S.A., INC. | $51.91 | 2019 | |
| Shield Therapeutics INC | $44.65 | 2025 | |
| E.R. Squibb & Sons, L.L.C. | $44.63 | 2019-2024 | Eliquis |
| Radius Health, INC. | $33.34 | 2019 | |
| Therapeuticsmd, INC. | $32.84 | 2019 | |
| Boston Scientific Corporation | $29.59 | 2025 | General - Pain Management |
| Irhythm Technologies, INC. | $27.55 | 2022 | |
| Teleflex LLC | $23.81 | 2025 | Barrigel |
| Si-Bone, INC. | $22.43 | 2024 | |
| Xeris Pharmaceuticals, INC. | $21.13 | 2025 | Gvoke Hypopen |
| Novartis Pharmaceuticals Corporation | $19.30 | 2019 | |
| Abbott Laboratories | $17.34 | 2020 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $15.57 | 2023 | Xifaxan |
| Cequr Corporation | $12.95 | 2022 | |
| Teva Pharmaceuticals USA, INC. | $12.89 | 2020 | |
| Tactile Systems Technology INC | $12.49 | 2022 | |
| Biowound Solutions, INC. | $10.70 | 2025 | Bio-Connekt |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw David Carty listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.